10 February 2023

BSF Enterprise plc

("BSF" or the "Company")

Allotment of shares‎‎ 

BSF Enterprise plc (LSE: BSFA), an investment company focused on unlocking the next generation of biotech solutions, announces‎ that on 10 August 2022, it allotted 203,528 ‎new ordinary shares of 1p ("New Ordinary Shares") at an issue price of 7.37 pence per share.

Applications will be made to the Financial Conduct Authority ("FCA") for admission of the New Ordinary Shares to the standard segment of the FCA's Official List and to the London Stock Exchange for admission of the Shares to trading on the London Stock Exchange's Main Market for listed securities ("Admission").  Admission is expected to take place on or around 15 February 2023.

The New Ordinary Shares are credited as fully paid and rank pari passu in all respects with the existing ordinary shares of the Company.

The Company acknowledges that due to administrative oversight, no announcement of the allotment of the New Ordinary Shares or applications for Admission were made at the time of the allotment.

The Company confirms that as at the date of this announcement, the Company's issued share capital comprises ‎85,986,937‎ ordinary shares of £0.01 each, with each share carrying the right to one vote. The Company does not hold any ordinary shares in treasury. The above figure of 85,986,937‎ may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or of a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

For further enquiries, please visit www.bsfenterprise.com or contact:

LEI: ‎‎2138007PJT69H8FYLC06‎